期刊文献+

膀胱肿瘤灌注化疗患者尿路感染相关因素分析 被引量:10

Related factors for urinary tract infections in bladder cancer patients undergoing postoperative intravesical irrigation chemotherapy
原文传递
导出
摘要 目的探讨膀胱肿瘤术后行膀胱灌注化疗患者尿路感染的相关因素,为制定有针对性的预防对策提供参考依据。方法选择2012年7月-2013年10月泌尿外科收治的114例膀胱肿瘤术后行膀胱灌注化疗患者临床资料,调查分析患者性别、年龄、灌注次数、留置导尿管、合并症及细菌培养结果,数据采用SPSS 19.0软件进行统计分析。结果 114例膀胱灌注化疗患者发生尿路感染41例,感染率35.96%;尿路感染患者的送检标本中共分离出病原菌49株,其中革兰阴性菌35株占71.43%,革兰阳性菌12株占24.49%,真菌2株占4.08%;年龄≥70岁、膀胱灌注>7次、留置导尿管、合并糖尿病及前列腺增生是膀胱肿瘤术后行膀胱灌注化疗患者尿路感染的独立危险因素。结论膀胱肿瘤术后行膀胱灌注化疗的患者尿路感染率较高,导致尿路感染发生的危险因素较多,应采取有效的预防措施,减少尿路感染的发生。 OBJECTIVE To explore the related factors for urinary tract infections in bladder cancer patients undergoing postoperative intravesical irrigation chemotherapy so as to formulate targeted prevention countermeasures.METHODS The clinical data were collected from 114 bladder cancer patients who underwent the postoperative intravesical irrigation chemotherapy in the department of urology from Jul 2012 to Oct 2013.A survey was conducted for the gender,age,number of times of irrigation,urinary catheter indwelling,complications,and results of bacterial culture;the statistical analysis of data was performed with the use of SPSS 19.0software.RESULTS The urinary tract infections occurred in 41 of 114patients who underwent the intravesical irrigation chemotherapy,with the infection rate 35.96%.A total of 49 strains of pathogens were isolated from the submitted specimens of the patients with urinary tract infections,including 35(71.43%)strains of gram-negative bacteria,12(24.49%)strains of gram-positive bacteria,and 2(4.08%)strains of fungi.The independent risk factors for the urinary tract infections in the bladder cancer patients undergoing the postoperative intravesical irrigation chemotherapy included the no less than 70 years of age,more than 7times of intravesical irrigation,urinary catheter indwelling,complication of diabetic mellitus,and prostatic hyperplasia.CONCLUSION The incidence rate of urinary tract infections is high in the bladder cancer patients undergoing the postoperative intravesical irrigation chemotherapy.There are a variety of risk factors for the urinary tract infections.It is necessary to take effective prevention measures so as to reduce the incidence of urinary tract infections.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第12期2817-2818,2824,共3页 Chinese Journal of Nosocomiology
基金 河南省医学科技攻关计划基金资助项目(201403125)
关键词 膀胱肿瘤术 膀胱灌注化疗 尿路感染 预防对策 Bladder cancer surgery Intravesical irrigation chemotherapy Urinary tract infection Prevention countermeasure
  • 相关文献

参考文献5

二级参考文献23

  • 1周芳坚,刘卓炜,余绍龙,韩辉,秦自科,李永红,王欢.改良全膀胱切除原位新膀胱术96例报告[J].中华泌尿外科杂志,2006,27(8):549-551. 被引量:39
  • 2Garcia CP,Rubilar PC, Vicentini HD,et al. Clinical and mo lecular characterixation of ESBL-productng enterobaeteria i solated from bacteremia in a university hospital[J]. Rev Chil ena Infectol,2011,28(6) :563-571.
  • 3Bernard MS, Hunter KF, Moore KN. A review of strategies to decrease the duration of indwelling urethral catheters and potentially reduce the incidence of cartheter-associated urina- ry tract infections[J]. Urologic nursing, 2012,32(1) : 29-37.
  • 4Gupta RS. Origin of diderm(Gram-negative) bacteria: antibi otie selection pressure rather than endoymbiosis likely led to the evolution of bacterial cell with two membranes[J]. Anton Leeuwenhoek, 2011,100(2) :171-182.
  • 5ZIETMAN AL, GROCELA J, ZEHR E, et al. Selective bladder conservation using transurethral resection, chemotherapy and radi- ation:management and consequences of T., T1 and Tis recurrence within the retained bladder[J], Urology, 2001, 58(3): 380-385.
  • 6SHIPLEY WU, KAUFMAN DS, ZEHR E, et al. Selective blad- der preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer[J]. Urology, 2012, 60(1): 62-67.
  • 7HERR HW. The value of second transurethral resection in eval- uating patients with bladder tumors[J]. J Urol, 1999, 162(1): 74- 76.
  • 8MARIAPPAN P, ZACHOU A, GRIGOR KM, et al. Detrusor- muscle in the first, apparently complete transurethral resection of bladder tumour specimen is asurrogate marker of resection quali- ty,predicts risk of early recurrence, and is dependent on opera- torexperience[J]. Ear Urol, 2010, 57(5): 843-849.
  • 9GAYA JM, PALOU J, COSENTINO M, et al. A second transurethral resection could be not necessary in all high grade nonmuscle invasive bladder tumors[J]. Actas Urol Esp, 2012, 36(9): 539-544.
  • 10MILADI M, PEYROMAURE M, ZERBIB M, et al. The value of a second transurethral resection in evaluating patients with blad- der tumors[J]. Eur Urol, 2003., 43(3): 241-245.

共引文献45

同被引文献85

引证文献10

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部